The Population Council congratulates Irving Sivin, a recipient of the Society of Family Planning Lifetime Achievement Award and a former senior scientist at the Center for Biomedical Research at the Population Council. The award recognizes Sivin for his commitment to family planning research.
Sivin is best known for his statistical analyses that led to the development and availability of some of most effective and widely used contraceptive technologies available today, including the intrauterine device ParaGard® (Copper T 380A) and the contraceptive implants Norplant® and Jadelle®. Among his hundreds of peer-reviewed papers and publications, he is the author of the Copper T 380 Intrauterine Device monograph, A Summary of Scientific Data, which can be downloaded here.
“Irv Sivin is a giant in the fields of reproductive health and family planning,” said Jim Sailer, executive director of the Center for Biomedical Research at the Population Council. “Irv dedicated his career – more than 40 years – to assessing the effectiveness of family planning programs and products. He helped put long-acting reversible forms of contraception on the map, and the world should be grateful for that.”
While at the Council, Sivin also conducted some of the early statistical analyses of Annovera™ (segesterone acetate and ethinyl estradiol vaginal system), the first and only contraceptive that provides an entire year of protection against unintended pregnancy while fully under a woman’s control.
For his many achievements, Sivin has previously received a Lifetime Achievement Award from Planned Parenthood. Sivin served on the Board of Directors of the European Society for Contraception and Reproductive Health Care (ESC) from 2008-2016. He was also elected twice as an Editor of the ESC’s Journal (2010-18).